Stay updated on Gene Therapy Study in Severe Haemophilia A Patients Clinical Trial
Sign up to get notified when there's something new on the Gene Therapy Study in Severe Haemophilia A Patients Clinical Trial page.

Latest updates to the Gene Therapy Study in Severe Haemophilia A Patients Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has been updated to reflect new results and data regarding the study of BMN 270 for severe Haemophilia A, including specific metrics on treatment efficacy and adverse events. Notably, the previous study on valoctocogene roxaparvovec has been removed.SummaryDifference47%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check80 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.2%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
Stay in the know with updates to Gene Therapy Study in Severe Haemophilia A Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gene Therapy Study in Severe Haemophilia A Patients Clinical Trial page.